Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104582173 | 10458217 | 3 | F | 20140617 | 20160809 | 20140917 | 20160815 | EXP | GB-AMGEN-GBRCT2014070714 | AMGEN | 49.00 | YR | A | F | Y | 114.00000 | KG | 20160815 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104582173 | 10458217 | 1 | PS | etanercept | ETANERCEPT | 1 | Unknown | 25 MG, 2X/WEEK | 5374.90088 | MG | Y | 103795 | 25 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | BIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104582173 | 10458217 | 1 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104582173 | 10458217 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104582173 | 10458217 | Cellulitis | |
| 104582173 | 10458217 | Influenza like illness | |
| 104582173 | 10458217 | Malaise | |
| 104582173 | 10458217 | Peripheral swelling | |
| 104582173 | 10458217 | Renal failure | |
| 104582173 | 10458217 | Sepsis | |
| 104582173 | 10458217 | Viral infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104582173 | 10458217 | 1 | 20120528 | 20140624 | 0 |